BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

573 related articles for article (PubMed ID: 19466980)

  • 21. Current options for the treatment of idiopathic thrombocytopenic purpura.
    Arnold DM; Kelton JG
    Semin Hematol; 2007 Oct; 44(4 Suppl 5):S12-23. PubMed ID: 18096468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A role of autoantibody-mediated platelet destruction in thrombocytopenia in patients with cirrhosis.
    Kajihara M; Kato S; Okazaki Y; Kawakami Y; Ishii H; Ikeda Y; Kuwana M
    Hepatology; 2003 Jun; 37(6):1267-76. PubMed ID: 12774004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suspects in the tale of lupus-associated thrombocytopenia.
    Ziakas PD; Routsias JG; Giannouli S; Tasidou A; Tzioufas AG; Voulgarelis M
    Clin Exp Immunol; 2006 Jul; 145(1):71-80. PubMed ID: 16792676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Some unsettled questions in childhood thrombocytopenia caused by immunologic platelet destruction (acute and chronic ITP).
    Gaedicke G; Schulze H
    Pediatr Blood Cancer; 2006 Oct; 47(5 Suppl):668-70. PubMed ID: 16933247
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD4+CD25+Foxp3+ regulatory T cells in the pathophysiology of immune thrombocytopenia.
    Nishimoto T; Kuwana M
    Semin Hematol; 2013 Jan; 50 Suppl 1():S43-9. PubMed ID: 23664516
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autoimmune thrombocytopenia: flow cytometric determination of platelet-associated autoantibodies against platelet-specific receptors.
    Tomer A; Koziol J; McMillan R
    J Thromb Haemost; 2005 Jan; 3(1):74-8. PubMed ID: 15634268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathophysiology of Autoimmune Thrombocytopenia: Current Insight with a Focus on Thrombopoiesis.
    Marini I; Bakchoul T
    Hamostaseologie; 2019 Aug; 39(3):227-237. PubMed ID: 30802916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic idiopathic thrombocytopenic purpura: mechanisms of pathogenesis.
    Gernsheimer T
    Oncologist; 2009 Jan; 14(1):12-21. PubMed ID: 19144680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathophysiology and management of primary immune thrombocytopenia.
    Kashiwagi H; Tomiyama Y
    Int J Hematol; 2013 Jul; 98(1):24-33. PubMed ID: 23702914
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical correlates in patients with elevated platelet-associated immunoglobulins.
    Szal M; Blumberg N
    Ann Clin Lab Sci; 1988; 18(1):24-33. PubMed ID: 3355094
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Idiopathic thrombocytopenic purpura and dysmegakaryocytopoiesis.
    Wang L; Li Y; Hou M
    Crit Rev Oncol Hematol; 2007 Nov; 64(2):83-9. PubMed ID: 17900920
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thrombopoietic agents in immune thrombocytopenia.
    Ghanima W; Bussel JB
    Semin Hematol; 2010 Jul; 47(3):258-65. PubMed ID: 20620437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mathematical analysis of the relative contributions of decreased production and increased peripheral destruction in idiopathic thrombocytopenic purpura and implications in splenectomy.
    Hersh J
    J Theor Biol; 2000 Mar; 203(2):153-62. PubMed ID: 10704299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deficient in vitro megakaryocytopoiesis and decreased in vivo platelet turnover in children and young adults with chronic thrombocytopenia.
    Parker RI; Siegel RS; Ratajczak MZ; Gewirtz AM
    J Pediatr Hematol Oncol; 1998; 20(3):196-201. PubMed ID: 9628429
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platelet destruction in immune thrombocytopenia. Understanding the mechanisms.
    Bakchoul T; Sachs UJ
    Hamostaseologie; 2016 Aug; 36(3):187-94. PubMed ID: 25982994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV-related thrombocytopenia.
    Scaradavou A
    Blood Rev; 2002 Mar; 16(1):73-6. PubMed ID: 11914001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic thrombocytopenia of childhood: use of non-invasive methods in clinical evaluation.
    Rajantie J; Javela K; Joutsi-Korhonen L; Kekomäki R
    Eur J Haematol; 2004 Apr; 72(4):268-72. PubMed ID: 15089765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pathogenic relevance of platelet-associated autoantibodies in chronic ITP--studies before and after splenectomy in three patients with chronic ITP by direct immunoprecipitation procedure].
    Tomiyama Y; Take H; Kosugi S; Kashiwagi H; Kanayama Y; Kurata Y; Matsuzawa Y
    Rinsho Ketsueki; 1993 Jan; 34(1):21-7. PubMed ID: 8450603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathogenesis and management of chronic idiopathic thrombocytopenic purpura: an update.
    Yang R; Han ZC
    Int J Hematol; 2000 Jan; 71(1):18-24. PubMed ID: 10729989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thrombosis in patients with primary chronic immune thrombocytopenia.
    Nørgaard M
    Thromb Res; 2012 Oct; 130 Suppl 1():S74-5. PubMed ID: 23026671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.